5 Participants Needed

CranioSacral Therapy for Parkinson's Disease

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Zia, Al Raza
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

We are studying \& researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.

Research Team

AR

Al Raza, CST

Principal Investigator

IBR, Inc.

Eligibility Criteria

This trial is for individuals who have been diagnosed with Parkinson's Disease. It aims to include those specifically suffering from this condition and excludes anyone who does not have Parkinson's Disease.

Inclusion Criteria

I have been diagnosed with Parkinson's Disease.

Exclusion Criteria

I do not have Parkinson's Disease.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive CranioSacral Integrative therapy for Parkinson's Disease, with biweekly sessions lasting 90 minutes each over 3 months

12 weeks
6 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Biweekly Intervention
Trial Overview The study is testing the effects of CranioSacral Integrative Therapy on patients with Parkinson's Disease over a period of 3 months, involving biweekly therapy sessions lasting 90 minutes each.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: biweekly interventionExperimental Treatment1 Intervention
biweekly intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Zia, Al Raza

Lead Sponsor

Trials
1
Recruited
5+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security